ALX Oncology/$ALXO
About ALX Oncology
Ticker
Industry
Employees
ALX Oncology Metrics
$89M
-
-$2.97
1.04
-
Price and volume
Market cap
$89M
Beta
1.04
52-week high
$17.83
52-week low
$1.19
Average daily volume
1.2M
Financial strength
Current ratio
4.821
Quick ratio
4.631
Long term debt to equity
11.324
Total debt to equity
12.688
Interest coverage (TTM)
-93.11%
Management effectiveness
Return on assets (TTM)
-49.24%
Return on equity (TTM)
-98.94%
Valuation
Price to book
0.65
Price to tangible book (TTM)
0.65
Price to free cash flow (TTM)
-0.662
Growth
Earnings per share change (TTM)
-16.85%
3-year earnings per share growth (CAGR)
16.81%
What the Analysts think about ALX Oncology
Analyst Ratings
ALX Oncology Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
ALX Oncology Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
ALX Oncology News
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
FAQs
What’s the current market cap for ALX Oncology stock?
What is the P/E ratio for ALX Oncology stock?
Does ALX Oncology stock pay dividends?
No, ALX Oncology (ALXO) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next ALX Oncology dividend payment date?
ALX Oncology (ALXO) stock does not pay dividends to its shareholders.
What is the beta indicator for ALX Oncology?
ALX Oncology (ALXO) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.